Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI)

PHASE4UnknownINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2020

Conditions
Coronary In-stent Restenosis
Interventions
DEVICE

Bioresorbable vascular scaffold

Trial Locations (19)

15006

Complexo Universitario Hospitalario de Santiago, Santiago de Compostela

18014

Hospital Universitario Virgen de las Nieves, Granada

24071

Complejo Asistencial de León, León

28006

Hospital Universitario de La Princesa, Madrid

28034

Hospital Ramón y Cajal, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital Universitario La Paz, Madrid

28222

Hospital Universitario Puerta de Hierro, Majadahonda

33006

Hospital Central de Asturias, Oviedo

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

39008

Hospital Universitario Marqués de Valdecilla, Santander

45004

Complejo Hospitalario de Toledo, Toledo

47005

Hospital Clínico Universitario de Valladolid, Valladolid

48960

Hospital de Galdakao, Vizcaya

06080

Hospital Universitario Infanta Cristina, Badajoz

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

08035

Hospital Universitari Vall d´Hebron, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

OTHER

collaborator

Instituto de Investigación Sanitaria Hospital Universitario de la Princesa

OTHER

collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Terumo Medical Corporation

INDUSTRY

lead

Spanish Society of Cardiology

OTHER

NCT02672878 - Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) | Biotech Hunter | Biotech Hunter